160 Health International Limited (2656) announced that a non-executive director, Mr. Zhang, resigned with effect from March 2, 2026. According to the announcement, he resigned due to personal commitments and confirmed no disagreement with the Board. Concurrently, Mr. Liu, who has extensive experience in internet product development, has been appointed as a non-executive director and appointed to the Audit Committee with effect from the same date.

The Audit Committee’s composition was adjusted on March 2, 2026. The committee now comprises Mr. Wang as Chairman, with Mr. Liu and Dr. Xu serving as members. The remuneration and nomination committees under the Board remain unchanged.